Apollo Hospitals Enterprise Ltd - 508869 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
As per annexure enclosed18-11-2021
18-11-2021
Apollo Hospitals' Q2 raises hope on outlook
The healthcare services division of Apollo saw 75% y-o-y rise in consolidated revenues in Q2.A strong revival in non-covid business and local market share gains boosted Apollo's prospects17-11-2021
Q2 performance shows Apollo Hospitals Enterprise in the pink of health
Most analysts are positive but target prices indicate limited upside15-11-2021
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations, 2015 (Regulations) regarding loss of share certificate. This is to inform you that the Company has received intimation from shareholders on November 15, 2021 regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos. 4806 Meera Bai P 74 354807 5843023 to 5843096 11034 Viswanatha Reddy 100 361038 8549399 to 8549498 11036 Viswanatha Reddy P 200 361040 8549699 to 8549898 11037 Viswanatha Reddy P 150 361041 8549899 to 8550048 This is for your information.15-11-2021
Earnings Call for Q2FY22 of Apollo Hospitals Enterprise
Conference Call with Apollo Hospitals Enterprise Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.15-11-2021
Q2FY22 Quarterly Result Announced for Apollo Hospitals Enterprise Ltd.
Highlights: Apollo Hospitals set to acquire a majority stake in 180-bed Excelcare Hospitals in Guwahati. Acquisition strengthens Apollo's leadership position in the city, with a combined capacity now of 400 beds (including the existing hospital) Indicates Group's strong focus on the North East, and intent to provide high quality healthcare across the country Q2 FY22 Consolidated Revenues of Rs 37,171 mio (growth of 35% yoy). Q2 FY22 Consolidated EBITDA (Post Ind AS 116) of Rs 6,150 mio. New Hospitals (excl Proton) reported an EBITDA of Rs 1,277 mio in Q2 FY22 as compared to an EBITDA of Rs 387 mio in Q2 FY21. Proton reported EBITDA (Post Ind AS 116) of Rs 139 mio in Q2 FY22 as compared to EBITDA loss of Rs (19) mio in Q2 FY21. AHLL reported EBITDA (Post Ind AS 116) of Rs 621 mio in Q2 FY22 as compared to EBITDA Rs 213 mio in Q2FY21. Consolidated PAT of Rs 2,478 mio in Q2 FY22, Ind-AS 116 on operating lease impacted reported PBT in Q2FY22 to the extent of Rs 116 mio Result PDF15-11-2021
Rare case of post-dengue mucormycosis reported at Delhi's Apollo Hospital
The patient had come to the hospital complaining about a sudden loss of vision in one eye, 15 days after his recovery from the vector-borne disease.13-11-2021
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Investor Presentation
As per annexure enclosed13-11-2021
Apollo Hospitals posts over three-fold jump in profit to Rs 267 crore
Apollo Hospitals to acquire Excelcare for Rs 210 crore13-11-2021